These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 17059519)

  • 1. Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care.
    Aanen MC; Weusten BL; Numans ME; de Wit NJ; Baron A; Smout AJ
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1377-84. PubMed ID: 17059519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease?
    Vakil N
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():64-9. PubMed ID: 16042661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
    Pace F; Bollani S; Molteni P; Bianchi Porro G
    Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
    Bautista J; Fullerton H; Briseno M; Cui H; Fass R
    Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: alternative approaches to the long-term management of GERD.
    Fennerty MB
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():39-44. PubMed ID: 16303036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of characteristics and disease management between subjects with frequent and occasional gastro-oesophageal reflux symptoms.
    Bretagne JF; Honnorat C; Richard-Molard B; Caekaert A; Barthélemy P
    Aliment Pharmacol Ther; 2006 Mar; 23(5):607-16. PubMed ID: 16480400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial oesophageal integrated acidity is a reliable predictor of gastro-oesophageal reflux disease.
    Shih GL; Brensinger CM; Katzka DA; Metz DC
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1475-82. PubMed ID: 15948815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study.
    Jaspersen D; Labenz J; Willich SN; Kulig M; Nocon M; Leodolter A; Lind T; Meyer-Sabellek W; Vieth M; Stolte M; Malfertheiner P
    Dig Liver Dis; 2006 Apr; 38(4):233-8. PubMed ID: 16413233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
    Delaney B; McColl K
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():32-40. PubMed ID: 16042657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy.
    Qua CS; Wong CH; Gopala K; Goh KL
    Aliment Pharmacol Ther; 2007 Feb; 25(3):287-95. PubMed ID: 17269990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: a prospective observational study.
    Bretagne JF; Rey JF; Caekaert A; Barthélemy P
    Dig Liver Dis; 2005 Aug; 37(8):566-70. PubMed ID: 15886080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease.
    Katz PO; Tutuian R
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):371-84. PubMed ID: 11403533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis: the efficacy of proton pump inhibitors for laryngeal symptoms attributed to gastro-oesophageal reflux disease.
    Gatta L; Vaira D; Sorrenti G; Zucchini S; Sama C; Vakil N
    Aliment Pharmacol Ther; 2007 Feb; 25(4):385-92. PubMed ID: 17269993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharyngolaryngeal reflux in outpatient clinical practice: personal experience.
    Galli J; Scarano S; Agostino S; Quaranta N; Cammarota G; Ottaviani F
    Acta Otorhinolaryngol Ital; 2003 Feb; 23(1):38-42. PubMed ID: 12812134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor.
    Gardner JD; Sloan S; Robinson M; Miner PB
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1381-6. PubMed ID: 15606401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personal view: rationale and proposed algorithms for symptom-based proton pump inhibitor therapy for gastro-oesophageal reflux disease.
    Bytzer P; Blum AL
    Aliment Pharmacol Ther; 2004 Aug; 20(4):389-98. PubMed ID: 15298632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--Bilitec, intraluminal impedance and Bravo capsule pH monitoring.
    Hirano I
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():12-24. PubMed ID: 16483266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms.
    Sifrim D; Mittal R; Fass R; Smout A; Castell D; Tack J; Gregersen H
    Aliment Pharmacol Ther; 2007 May; 25(9):1003-17. PubMed ID: 17439501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease.
    Gunaratnam NT; Jessup TP; Inadomi J; Lascewski DP
    Aliment Pharmacol Ther; 2006 May; 23(10):1473-7. PubMed ID: 16669962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.